Bulletin
Investor Alert

London Markets Open in:

Revolution Medicines Inc.

NAS: RVMD

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Oct 4, 2022, 4:02 p.m.

/zigman2/quotes/216320743/composite

$

20.00

Change

0.00 0.00%

Volume

Volume 169,529

Quotes are delayed by 20 min

/zigman2/quotes/216320743/composite

Previous close

$ 19.53

$ 20.00

Change

+0.47 +2.41%

Day low

Day high

$19.49

$20.49

Open

52 week low

52 week high

$14.08

$34.16

Open

Sushil Patel

Sushil Patel is on the board of Revolution Medicines, Inc. and Chief Commercial Officer at Replimune Group, Inc.

In his past career he occupied the position of Vice President-Franchise & Head-Oncology at Genentech, Inc.

Dr. Patel received a graduate degree from Imperial College London, a doctorate from the University of London and an undergraduate degree from the University of Warwick.

Transactions

Date Shares Transaction Value
06/16/2022 10,500   Award at $0 per share. 0

Officers and Executives

Dr. Mark A. Goldsmith
Chairman, President & Chief Executive Officer
Dr. Margaret A. Horn
Chief Operating Officer & General Counsel
Mr. Jack Anders
Chief Financial Officer
Dr. Stephen M. Kelsey
President-Research & Development
Dr. Walter Reiher
Chief Information Officer
Dr. Xiao Lin Wang
Executive Vice President-Clinical Development
Dr. Sushil Patel
Director
Ms. Luan M. Wilfong
Senior Vice President-Human Resources
Mr. Jeff Cislini
Secretary, Senior Vice President & General Counsel
Dr. Eric Schmidt
Independent Director
Dr. Flavia Borellini
Independent Director
Dr. Lorence H. Kim
Independent Director
Ms. Elizabeth McKee Anderson
Independent Director
Mr. Alexis A. Borisy
Lead Independent Director
Dr. Thilo Schroeder
Independent Director
Dr. Barbara L. Weber
Independent Director
Link to MarketWatch's Slice.